Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;396(1):167-170.
doi: 10.1007/s00210-022-02334-z. Epub 2022 Nov 16.

Pharmacokinetics of chromium-enriched yeast in rats following oral administration

Affiliations

Pharmacokinetics of chromium-enriched yeast in rats following oral administration

Shuang-Qing Zhang et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan.

Abstract

Chromium (Cr) is required for carbohydrate, lipid, and protein metabolisms in humans and animals. Cr insufficiency is associated with diabetes and cardiovascular disease. Chromium-enriched yeast (CrY) is a widely used Cr dietary supplement, but its pharmacokinetics remains unavailable. CrY was orally administered to rats at a single dose of 1 mg Cr/kg, and plasma Cr concentration at different time points was measured by inductively coupled plasma mass spectrometry. Pharmacokinetics of CrY in rats was well fitted to a non-compartmental model. Plasma Cr concentration reached the maximum of 8.68 ± 2.87 ng/mL at 0.25 h, and gradually decreased to 4.05 ± 0.47 ng/mL at 24 h. CrY was rapidly absorbed into the blood and was slowly eliminated after the oral administration, which could lead to the accumulation of Cr in vivo.

Keywords: Chromium; Chromium-enriched yeast; Pharmacokinetic parameter; Pharmacokinetics.

PubMed Disclaimer

References

    1. Authority EFS (2009) Inability to assess the safety of chromium-enriched yeast added for nutritional purposes as a source of chromium in food supplements and the bioavailability of chromium from this source, based on the supporting dossiers. EFSA J 7(6):1083. https://doi.org/10.2903/j.efsa.2009.1083 - DOI
    1. Cheng HH, Lai MH, Hou WC, Huang CL (2004) Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem 52(5):1385–1389. https://doi.org/10.1021/jf035074j - DOI
    1. Chinese Nutrition Society (2014) Chinese dietary reference intakes 2013. Science Press, China
    1. Collins BJ, Stout MD, Levine KE, Kissling GE, Melnick RL, Fennell TR, Walden R, Abdo K, Pritchard JB, Fernando RA, Burka LT, Hooth MJ (2010) Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice. Toxicol Sci 118(2):368–379. https://doi.org/10.1093/toxsci/kfq263 - DOI
    1. Febel H, Szegedi B, Huszar S (2001) Absorption of inorganic, trivalent and hexavalent chromium following oral and intrajejunal doses in rats. Acta Vet Hung 49(2):203–209. https://doi.org/10.1556/004.49.2001.2.10 - DOI

LinkOut - more resources